Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Cyclerion Therapeutics (CYCN) over the last 7 years, with Q3 2025 value amounting to -$76000.0.

  • Cyclerion Therapeutics' Other Working Capital Changes fell 11504.95% to -$76000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$235000.0, marking a year-over-year decrease of 43409.09%. This contributed to the annual value of -$21000.0 for FY2024, which is 9421.49% up from last year.
  • Cyclerion Therapeutics' Other Working Capital Changes amounted to -$76000.0 in Q3 2025, which was down 11504.95% from $206000.0 recorded in Q2 2025.
  • In the past 5 years, Cyclerion Therapeutics' Other Working Capital Changes registered a high of $505000.0 during Q3 2024, and its lowest value of -$774000.0 during Q1 2021.
  • For the 5-year period, Cyclerion Therapeutics' Other Working Capital Changes averaged around -$94000.0, with its median value being -$165000.0 (2025).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first skyrocketed by 259000.0% in 2022, then tumbled by 40126.58% in 2023.
  • Cyclerion Therapeutics' Other Working Capital Changes (Quarter) stood at $10000.0 in 2021, then soared by 2590.0% to $269000.0 in 2022, then crashed by 182.9% to -$223000.0 in 2023, then rose by 10.31% to -$200000.0 in 2024, then skyrocketed by 62.0% to -$76000.0 in 2025.
  • Its Other Working Capital Changes stands at -$76000.0 for Q3 2025, versus $206000.0 for Q2 2025 and -$165000.0 for Q1 2025.